Fiji has declared a national emergency in response to what public health specialists describe as the world's fastest-growing HIV epidemic. Driven by a surge in crystal methamphetamine addiction among young adults, HIV infections in the Pacific island nation escalated 12-fold between 2010 and 2025. Health authorities estimate that more than 9,000 people are living with the virus—representing roughly 1 in 60 adults nationwide—with two-thirds of all cases concentrated among individuals aged 20 to 34.
The health crisis stems largely from a shift in how methamphetamine is consumed across the country. Historically a transit hub for drug trafficking between South America and Australasia, Fiji experienced a sharp rise in domestic drug use following pandemic-related travel restrictions and heightened border security, which trapped narcotics within local markets. Amid widespread job losses and economic hardship, consumption shifted from smoking to intravenous injection. A scarcity of clean needles—exacerbated by law enforcement crackdowns—and a cultural tradition of sharing have fostered practices such as "bluetoothing," where users inject blood from an infected individual to share a high. Officials report that an infected person transmits the virus to an average of ten others.
Unprotected sexual intercourse also accounted for approximately half of all new HIV diagnoses in 2025. Public health surveys reveal exceptionally low rates of condom usage among demographics with multiple partners, accelerating community transmission alongside needle sharing. The outbreak has increasingly affected newborns, with 59 infants born with HIV in 2025 alone.
To stem the spread, the Australian government announced a $48 million aid package in August to expand early diagnosis, treatment, and preventive care. Priority initiatives include rolling out universal HIV screening across all antenatal clinics to ensure pregnant women receive antiretroviral therapy to prevent mother-to-child transmission. However, public health experts warn that reaching the most vulnerable populations remains challenging, as high rates of poverty and homelessness among drug users hinder consistent testing and medical care.